Flavones: An important scaffold for medicinal chemistry

European Journal of Medicinal Chemistry

Volumn 84, Issue , 2014, Pages 206-239

  Singh, Manjinder ^a   Kaur, Maninder ^a   Silakari, Om ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Antioxidant; Flavones; Flavonoids; Multi factorial diseases; Poly functional

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIARRHEAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIPROTOZOAL AGENT; ANTIVIRUS AGENT; CATALASE; COSMETIC; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYCLIN DEPENDENT KINASE; FIBROBLAST GROWTH FACTOR 2; FLAVONE DERIVATIVE; IMMUNOMODULATING AGENT; INTERLEUKIN RECEPTOR; JANUS KINASE; LACTOYLGLUTATHIONE LYASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; SPASMOLYTIC AGENT; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 3; XANTHINE OXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANTHELMINTIC AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTILEISHMANIAL AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; CARDIOVASCULAR AGENT; CYTOPROTECTIVE AGENT; MOLECULAR SCAFFOLD; PHOSPHODIESTERASE INHIBITOR; VASODILATOR AGENT; XANTHINE OXIDASE INHIBITOR;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIDIABETIC ACTIVITY; ANTIDIARRHEAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIULCER ACTIVITY; ANTIVIRAL ACTIVITY; CANCER CELL; CLAISEN CONDENSATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; IMMUNOMODULATION; MEDICINAL CHEMISTRY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROSTATE HYPERTROPHY; PROTEIN PHOSPHORYLATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES; PATHOLOGY; ANGIOGENESIS; ANTHELMINTIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASTHMA; ATHEROGENESIS; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CELL PROTECTION; CROSS COUPLING REACTION; LIPID PEROXIDATION; MOLECULAR DOCKING; OSTEOPOROSIS; SPASMOLYSIS; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHEMISTRY, PHARMACEUTICAL; FLAVONES; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84904324976     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.07.013     Document Type: Review

References (316)

1. J.L. Richard, F. Cambien, and P. Ducimetiere Epidemiologic characteristics of coronary disease in France Nouv. Presse. Med. 10 1981 1111 1114 (Pubitemid 11096077)
2. R.J. Nijveldt, E.V. Nood, D. Hoorn, P.G. Boelens, K. Norren, and P. Leeuwen Flavonoids: a review of probable mechanisms of action and potential applications Am. J. Clin. Nutr. 74 2001 418 425 (Pubitemid 32880250)
3. T.P.T. Cushnie, and A.J. Lamb Antimicrobial activity of flavonoids Int. J. Antimicrob. Agents 26 2005 343 356 (Pubitemid 41483464)
4. B. Havsteen Flavonoids, a class of natural products of high pharmacological potency Biochem. Pharmacol. 32 1983 1141 1148 (Pubitemid 13135620)
5. E. Middleton, and K. Chithan The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer J.B. Harborne, The Flavonoids: Advances in Research Since 1986 1993 Chapman and Hall London pp145 166
6. C.T. Davis, and T.A. Geissman Basic dissociation constants of some substituted flavones J. Am. Chem. Soc. 76 1954 3507 3511
7. H. Simonis The hydrolysis of chromones by dilute alkali Ber. Dtsch. Chem. Ges. 50 1917 779 786
8. M. Suzuki, H. Mizuno, and M. Takai Hydrogenation of 5-hydroxy-, 7-hydroxy-, and 5, 7-dihydroxyflavone with a platinum catalyst. Selective hydrogen at ion of flavone derivatives Nippon. Kagaku. Zasshi 88 1967 675 678
9. D. Yang, M. Wong, and Y. Yip Epoxidation of olefins using methyl(trifluoromethyl)dioxirane generated in situ J. Org. Chem. 60 1995 3887 3889
10. D.M. Donnelly, E.M. Philbin, and T.S. Wheeler Wessely-Moser rearrangement of chromonols and flavonols J. Chem. Soc. 845 1956 4409 4411
11. M.T. Bogert, and J.K. Marcus The synthesis of aminoflavones, of flavone-azobeta-naphthol dyes, and of other flavone derivatives J. Am. Chem. Soc. 41 1919 83 107
12. X. Zheng, W. Meng, Y. Xu, J. Cao, and F. Qing Synthesis and anticancer effect of chrysin derivatives Bioorg. Med. Chem. Lett. 13 2003 881 884 (Pubitemid 36255559)
13. V.P. Khilya, and V.V. Ishchenko Flavones, isoflavones, and 2- and 3-hetarylchromones in reactions with hydroxylamine Chem. Heterocycl. Comp. 38 2002 883 899
14. P.D. Re, L. Verlicchi, and I. Setnikar Mannich reaction on 7-hydroxychromones and flavones. Synthesis of powerful central nervous system stimulants J. Org. Chem. 25 1960 1097 1100
15. H.I. Morris, and Z. Ahmed Styrylbenzopyrylium salts. Part VII. The conversion of 7-methoxy-2: 3-dimethylchromone into styrylpyrylium salts J. Chem. Soc. 126 1926 1902 1906
16. A. Schonberg, and E. Singer β-γ-unsaturated ketones: via addition of fluorene of flavones Chem. Ber. 94 1961 241 247
17. X. Zheng, W. Meng, and F. Qing Synthesis of gem-difluoromethylenated biflavonoid via the Suzuki coupling reaction Tetrahedron Lett. 45 2004 8083 8085 (Pubitemid 39303650)
18. K.V. Sashidhara, S.R. Avula, G.R. Palnati, S.V. Singh, K. Srivastava, S.K. Puri, and J.K. Saxena Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum Bioorg. Med. Chem. Lett. 22 2012 5455 5459
19. H.S. Mahal, and K. Venkataraman Synthetical experiments in the chromone group. Part XIV. The action of sodamide on 1-acyloxy-2-acetonaphthones J. Chem. Soc. 10 1934 1767 1769
20. W. Baker Molecular rearrangement of some o-acyloxyacetophenones and the mechanism of the production of 3-acylchromones J. Chem. Soc. 10 1933 1381 1389
21. S.R. Sarda, M.Y. Pathan, V.V. Paike, P.R. Pachmase, W.N. Jadhav, and R.P. Pawar A facile synthesis of flavones using recyclable ionic liquid under microwave irradiation Arkivoc 16 2006 43 48 (Pubitemid 44892625)
22. J. Allan, and R. Robinson An accessible derivative of chromonol J. Chem. Soc. 125 1924 2192 2195
23. W.K. Su, X.Y. Zhu, and Z.H. Li First Vilsmeier-Haack synthesis of flavones using bis-(trichloromethyl) carbonate/dimethylformamide Org. Prep. Proced. Int. 41 2009 69 75
24. K.V. Sashidhara, M. Kumar, and A. Kumar A novel route to synthesis of flavones from salicylaldehyde and acetophenone derivatives Tetrahedron Lett. 53 2012 2355 2359
25. R.E. Koes, F. Quattrocchio, and J.N.M. Mol The flavonoid biosynthetic pathway in plants: function and evolution Biossays 16 1994 123 132
26. I. Gulcin Antioxidant activity of L-adrenaline: an activity-structure insight Chem. Biol. Interact. 179 2009 71 80
27. B. Halliwell, R. Aeshbach, J. Loliger, and O.I. Aruoma The characterization of antioxidants Food Chem. Toxicol. 33 1995 601 617
28. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 1989 Clarendon Press Oxford 331
29. G. Cao, E. Sofic, and R.L. Prior Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships Free Radic. Biol. Med. 22 1997 749 760 (Pubitemid 27058337)
30. Z.Y. Chen, P.T. Chan, K.Y. Ho, K.P. Fung, and J. Wang Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups Chem. Phys. Lipids 76 1996 157 163 (Pubitemid 26143737)
31. J.M. McCord Superoxide radical: controversies, contradictions, and paradoxes Proc. Soc. Exp. Biol. Med. 209 1995 112 117
32. J. Greeff, J. Joubert, S.F. Malan, and S. Dyk Antioxidant properties of 4-quinolones and structurally related flavones Bio. Med. Chem. 20 2012 809 818
33. J. Hyun, Y. Woo, D. Hwang, G. Jo, S. Eom, Y. Lee, J.C. Park, and Y. Lim Relationships between structures of hydroxyflavones and their antioxidative effects Bio. Med. Chem. Lett. 20 2010 5510 5513
34. A. Gomes, O. Neuwirth, M. Freitas, D. Couto, D. Ribeiro, A. Fueiredo, A.M.S. Silva, R. Seixas, D. Pinto, A.C. Tome, J.A.S. Cavaleir, E. Fernandes, and J. Lima Synthesis and antioxidant properties of new chromone derivatives Bio. Med. Chem. 17 2009 7218 7226
35. S. Bosi, T.D. Ros, G. Spalluto, and M. Prato Fullerene derivatives: an attractive tool for biological applications Eur. J. Med. Chem. 38 2003 913 923 (Pubitemid 37455402)
36. R.F. Enes, A.S.F. Farinha, A.C. Tome, J.A.S. Cavaleiro, R. Amorati, S. Petrucci, and G.F. Pedulli Synthesis and antioxidant activity of [60]fullerene-flavonoid conjugates Tetrahedron 65 2009 253 262
37. R. Gazak, P. Sedmera, M. Vrbacky, J. Vostalova, Z. Drahota, P. Marhol, D. Walterova, and V. Kren Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity - role of individual hydroxyl groups Free Radic. Biol. Med. 46 2009 745 758
38. P.A. Lapchak, P. Maher, D. Schubert, and J.A. Zivin Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes Neuroscience 37 2007 585 591 (Pubitemid 350214501)
39. T. Herrerias, B. Oliveira, M. Gomes, M. Oliveira, M. Carnieri, S. Cadena, G. Martinez, and M. Rocha Eupafolin: Effect on mitochondrial energetic metabolism Bio. Med. Chem. 16 2008 854 861 (Pubitemid 351163061)
40. B. Mishra, I. Priyadarsini, S. Kumar, K. Unnikrishnan, and H. Mohan Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol Bio. Med. Chem. 11 2003 2677 2685 (Pubitemid 36682991)
41. H.W. Lu, K. Sugahara, Y. Sagara, N. Masuoka, Y. Asaka, M. Manabe, and H. Kodama Effect of three flavonoids, 5,7,39,49-tetrahydroxy-3-methoxy flavone, luteolin, and quercetin, on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophil Arch. Bio. Biophy. 393 2001 73 77 (Pubitemid 32808361)
42. H. Babich Butylated hydroxytoluene (BHT): a review Environ. Res. 29 1982 1 29 (Pubitemid 13204684)
43. J. Lebeau, C. Furman, J. Bernier, P. Duriez, E. Teissier, and N. Cotelle Antioxidant properties of di-tert-butylhydroxylated flavonoids Free Radic. Biol. Med. 29 2000 900 912
44. N. Cotelle, J. Bernier, J. Catteau, J. Pommery, J.C. Wallet, and E.M. Gaydou Antioxidant properties of hydroxy-flavones Free Radic. Biol. Med. 20 1996 35 43 (Pubitemid 26018504)
45. G. Kandaswami, E. Perkins, D.S. Soloniuk, G. Drzewiecki, and E. Middleton Ascorbic acid-enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro Anti Cancer Drugs 4 1993 91 96 (Pubitemid 23063739)
46. W.R. Markesbery, T.R. Montine, and M.A. Lovell M.P. Mattson, Pathogenesis of Neurodegenerative Disorders 2001 Humana Press New Jersey 21 52
47. W. Fu, H. Luo, S. Parthsarathy, and M.P. Mattson Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis Neurobiol. Dis. 5 1998 229 243 (Pubitemid 28519153)
48. P.G. Pietta Flavonoids as antioxidants J. Nat. Prod. 63 2000 1035 1042
49. P. Knekt, R. Järvinen, R. Seppänen, M. Hellövaara, L. Teppo, E. Pukkala, and A. Aromaa Dietary flavonoids and the risk of lung cancer and other malignant neoplasms Am. J. Epidemiol. 146 1997 223 230 (Pubitemid 27329723)
50. C. Nicolas, F. Sebastien, M.C. Martinez, and A. Ramaroson Anticancer properties of flavonoids: roles in various stages of carcinogenesis Cardiovasc. Hematol. Agents Med. Chem. 9 2011 62 77
51. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary flavonoids and cancer risk in the Zutphen Elderly Study Nutr. Cancer 22 1994 175 184 (Pubitemid 24310125)
52. S. Shukla, and S. Gupta Apigenin: a promising molecule for cancer prevention Pharm. Res. 27 2010 962 978
53. I. Diaz-Padilla, L.L. Siu, and I. Duran Cyclin-dependent kinase inhibitors as potential targeted anticancer agents Invest. New Drugs 27 2009 586 594
54. T.B. Nguyen, O. Lozach, G. Surpateanu, Q. Wang, P. Retailleau, B.I. Iorga, L. Meijer, and F. Gueritte Synthesis, biological evaluation, and molecular modeling of naturaland unnatural flavonoidal alkaloids, inhibitors of kinase J. Med. Chem. 55 2012 2811 2819
55. A.M. Senderowicz Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials Invest. New Drugs 17 1999 313 320 (Pubitemid 30037961)
56. N. Raje, T. Hideshima, S. Mukherjee, M. Raab, S. Vallet, S. Chhetri, D. Cirstea, S. Pozzi, C. Mitsiades, M. Rooney, T. Kiziltepe, K. Podar, Y. Okawa, H. Ikeda, R. Carrasco, P.G. Richardson, D. Chauhan, N.C. Munshi, S. Sharma, H. Parikh, B. Chabner, D. Scadden, and K.C. Anderson Preclinical activity of P276-00, a novel small molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma Leukemia 23 2009 961 970
57. W.H. Park MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition Mol. Med. Rep. 4 2011 193 204
58. Y. Muftuoglu, and G. Mustata Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19) Bioorg. Med. Chem. Lett. 20 2010 3050 3054
59. D. Ghosh, J. Griswold, M. Erman, and W. Pangborn Structural basis for androgen specificity and oestrogen synthesis in human aromatase Nature 457 2009 219 223
60. S. Gobbi, A. Cavalli, A. Bisi, and M. Recanatini From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer Curr. Top. Med. Chem. 8 2008 869 887 (Pubitemid 351984710)
61. M. Recanatini, A. Cavalli, and P. Valenti Nonsteroidal aromatase inhibitors: recent advances Med. Res. Rev. 22 2002 282 304 (Pubitemid 34415467)
62. J.R. Benson, and O. Ravisekar Aromatase inhibitors for treatment of breast cancer Curr. Cancer Ther. Rev. 3 2007 67 79 (Pubitemid 46510735)
63. M. Wang, G. Lacy, M. Gao, K.D. Miller, G.W. Sledge, and Q.H. Zheng Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer Bioorg. Med. Chem. Lett. 17 2007 332 336 (Pubitemid 46084911)
64. Q. Yuan, Z. Liu, C. Xiong, L. Wu, J. Wang, and J. Ruan A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4- one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1 Bioorg. Med. Chem. Lett. 21 2011 3427 3430
65. C. Pouget, F. Lauthier, A. Simon, C. Fagnere, J.P. Basly, C. Delage, and A.J. Chulia Flavonoids: structural requirements for antiproliferative activity on breast cancer cells Bioorg. Med. Chem. Lett. 2001 3095 3097 (Pubitemid 33092000)
66. A.R. Ibrahim, and Y.J. Abul-Hajj Aromatase inhibition by flavonoids J. Steroid. Biochem. Mol. Biol. 37 1990 257 260 (Pubitemid 20380547)
67. S. Gobbi, A. Cavalli, A. Rampa, F. Belluti, L. Piazzi, A. Paluszcak, R.W. Hartmann, M. Recanatini, and A. Bisi Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme J. Med. Chem. 49 2006 4777 4780 (Pubitemid 44162705)
68. N. Yao, C.Y. Chen, C.Y. Wu, K. Motonishi, H. Kung, and K.S. Lam Novel flavonoids with antiproliferative activities against breast cancer cells J. Med. Chem. 54 2011 4339 4349
69. Y. Kimura, and M. Sumiyoshi Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti- lymphangiogenesis Phytomedicine 20 2012 328 336
70. M.G. Ferlin, G. Chiarelotto, V. Gasparotto, L. Barzon, G. Palu, and I. Castagliuolo Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones J. Med. Chem. 48 2005 3417 3427 (Pubitemid 40628059)
71. M.G. Ferlin, M.T. Conconi, L. Urbani, B. Oselladore, D. Guidolin, R.D. Liddo, and P.P. Parnigotto Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones Bioorg. Med. Chem. 19 2011 448 457
72. J.A. Beutler, E. Hamel, A.J. Vlietinck, A. Haemers, P. Rajan, J.N. Roitman, J.H. Cardellina, and M.R. Boyd Structure-activity requirements for flavone cytotoxicity and binding to tubulin J. Med. Chem. 57 1998 2333 2338 (Pubitemid 28285735)
73. J.J. Lichius, O. Thoison, A. Montagnac, M. Pais, F. Gueritte-Voegelein, T. Sevenet, J.P. Cosson, and A.H. Hadi Antimitotic and cytotoxic flavonols from Zieridium pseudobtusifolium and Acronychia porteri J. Nat. Prod. 58 1994 1012 1016 (Pubitemid 24271342)
74. Q. Shi, K. Chen, L. Li, J.J. Chang, C. Autry, M. Kozuka, T. Konoshima, J.R. Estes, C.M. Lin, and E. Hamel Antitumor agents, 154, cytotoxic and antimitotic flavonols from Polanisia dodecandra J. Nat. Prod. 19 1995 475 482
75. G. Lewin, N.B. Shridhar, G. Aubert, S. Thoret, J. Dubois, and T. Cresteil Synthesis of antiproliferative flavones from calycopterin, major flavonoid of Calycopteris floribunda Lamk. Bioorg. Med. Chem. 19 2011 186 196
76. R.V. Bensasson, V. Zoete, A. Jossang, B. Bodo, P.B. Arimondo, and E.J. Land Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters Free Radic. Biol. Med. 51 2011 1406 1410
77. C.S. Lai, S. Li, C.Y. Chai, C.Y. Lo, S. Dushenkov, C.T. Ho, M.H. Pan, and Y.J. Wang Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3′,4′-didemethylnobiletin, derived from nobiletin Carcinogenesis 29 2008 2415 2424
78. T. Oshitari, Y. Okuyama, Y. Miyata, H. Kosano, H. Takahashi, and H. Natsugari Nobiletin metabolites: synthesis and inhibitory activity against matrix metalloproteinase-9 production Bioorg. Med. Chem. Lett. 21 2011 4540 4544
79. H.F. Lu, Y.J. Chie, M.S. Yang, C.S. Lee, J.J. Fu, J.S. Yang, T.W. Tan, S.H. Wu, Y.S. Ma, S.W. Ip, and J.G. Chung Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway Int. J. Oncol. 36 2010 1477 1484
80. J. Cai, X.L. Zhao, A.W. Liu, H. Nian, and S.H. Zhang Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns Phytomedicine 18 2011 366 373
81. X.H. Liu, H.F. Liu, X. Shen, B.A. Song, P.S. Bhadury, H.L. Zhu, J.X. Liu, and X.B. Qi Synthesis and molecular docking studies of novel 2-chloro pyridine derivatives containing flavone moieties as potential antitumor agents Bioorg. Med. Chem. Lett. 20 2010 4163 4167
82. A.J. Gillis, A.P. Schuller, and E. Skordalakes Structure of the Tribolium castaneum telomerase catalytic subunit TERT Nature 455 2008 633 637
83. P.J. Thornalley, L.G. Edwards, Y. Kang, C. Wyatt, N. Davies, M.J. Ladan, and J. Double Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis Biochem. Pharmacol. 51 1996 1365 1372 (Pubitemid 26142860)
84. R. Takasawa, S. Takahashi, K. Saeki, S. Sunaga, A. Yoshimori, and S. Tanuma Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects Bioorg. Med. Chem. 16 2008 3969 3975 (Pubitemid 351492539)
85. R. Medzhitov Inflammation 2010: new adventures of an old flame Cell 2010 771 776
86. S. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
87. C. Nathan Points of control in inflammation Nature 420 2002 846 852 (Pubitemid 36019637)
88. B.N. Cronstein, and G. Weissmann Targets for antiinflammatory drugs Annu. Rev. Pharmacol. Toxicol. 35 1995 449 462
89. C.A. Feghali, and T.M. Wright Cytokines in acute and chronic inflammation Front. Biosci. 2 1997 12 26
90. S.S. Bhagwat Kinase inhibitors for the treatment of inflammatory and autoimmune disorders Purinergic Signal 5 2009 107 115
91. C.A. Dinarello Anti-inflammatory agents: present and future Cell 140 2010 935 950
92. J.H. Yoon, and S.J. Baek Molecular targets of dietary polyphenols with anti-inflammatory properties Yonsei Med. J. 46 2005 585 596 (Pubitemid 41804732)
93. D.X. Hou, and T. Kumamoto Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling Antioxid. Redox. Signal. 13 2010 691 719
94. D.H. Kim, C.H. Yun, M.H. Kim, C.H. Naveen Kumar, B.H. Yun, J.S. Shin, H.J. An, Y.H. Lee, Y.D. Yun, H.K. Rim, M.S. Yoo, K.T. Lee, and Y.S. Lee 4′-Bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-jB signaling pathway in RAW 264.7 macrophages Bioorg. Med. Chem. Lett. 22 2012 700 705
95. S.Y. Shin, Y. Woo, J. Hyun, Y. Yong, D. Koh, Y.H. Lee, and Y. Lim Relationship between the structures of flavonoids and their NF-kB-dependent transcriptional activities Bioorg. Med. Chem. Lett. 21 2011 6036 6041
96. T. Oshitari, Y. Okuyama, Y. Miyata, H. Kosano, H. Takahashi, and H. Natsugari B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production Bioorg. Med. Chem. 19 2011 7085 7092
97. T.C. Moon, Z. Quan, J. Kim, H.P. Kim, I. Kudo, M. Murakami, H. Park, and H.W. Chang Inhibitory effect of synthetic C-C biflavones on various phospholipase A2s activity Bioorg. Med. Chem. 15 2007 7138 7143 (Pubitemid 47451783)
98. J. Chen, H.W. Chang, H.P. Kim, and H. Park Synthesis of phospholipase A2 inhibitory biflavonoids Bioorg. Med. Chem. Lett. 16 2006 2373 2375
99. Y. Takano-Ishikawa, M. Goto, and K. Yamaki Structure-activity relations of inhibitory effects of various flavonoids on lipopolysaccharide-induced prostaglandin E2 production in rat peritoneal macrophages: comparison between subclasses of flavonoids Phytomedicine 13 2006 310 317
100. R. Landolfi, R.L. Mower, and M. Steiner Modification of platelet function and arachidonic acid metabolism by bioflavonoids Biochem. Pharmacol. 33 1984 1525 1530 (Pubitemid 14105028)
101. H. Matsumoto, H. Naraba, M. Murakami, I. Kudo, K. Yamaki, A. Ueno, and S. Ohishi Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages Biochem. Biophys. Res. Commun. 230 1997 110 114 (Pubitemid 27210253)
102. V. Anuradha, P.V. Srinivas, R.,R. Rao, K. Manjulatha, M.G. Purohit, and J.M. Rao Isolation and synthesis of analgesic and anti-inflammatory compounds from Ochna squarrosa L. Bioorg. Med. Chem. 14 2006 6820 6826 (Pubitemid 44307658)
103. T. Nakatsuka, Y. Tomimori, Y. Fukuda, and H. Nukaya First total synthesis of structurally unique flavonoids and their strong anti-inflammatory effect Bioorg. Med. Chem. Lett. 14 2004 3201 3203 (Pubitemid 38624593)
104. T.T. Dao, Y.S. Chi, J. Kim, H.P. Kim, S. Kim, and H. Park Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives Bioorg. Med. Chem. 14 2004 1165 1167 (Pubitemid 38229848)
105. H. Matsuda, T. Morikawa, S. Ando, I. Toguchida, and M. Yoshikawa Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action Bioorg. Med. Chem. 11 2003 1995 2000 (Pubitemid 36379016)
106. H. Mastuda, T. Morikawa, K. Ueda, H. Managi, and M. Yoshikawa Structural requirements of flavonoids for inhibition of antigen-induced degranulation, TNF- and IL-4 production from RBL-2H3 cells Bioorg. Med. Chem. 10 2002 3123 3128 (Pubitemid 34855385)
107. R.L. Mower, R. Landolfi, and M. Steiner Inhibition ill vitro of platelet aggregation and arachidonic acid metabolism by flavones Biochem. Pharmacol. 33 1984 357 364
108. T.A. Pham, H. Che, P.T. Phan, J.W. Lee, S.S. Kim, and H. Park Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production Bioorg. Med. Chem. Lett. 22 2012 2534 2535
109. S.W. Jang, X. Liu, M. YepeS, K.R. Shepherd, G.W. Miller, Y. Liu, W.D. Wilson, G. Xiao, B. Blanchi, Y.E. Sun, and K. Ye A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc. Natl. Acad. Sci. U. S. A. 107 2010 2687 2692
110. X. Liu, C.B. Chan, S.W. Jang, S. Pradoldej, J. Huang, K. He, L.H. Phun, S. France, G. Xiao, Y. Jia, H.R. Luo, and K. Ye A synthetic 7,8-Dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect J. Med. Chem. 53 2010 8274 8286
111. X. Liu, C.B. Chan, Q. Qi, G. Xiao, H.R. Luo, X. He, and K. Ye Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxy flavone active in mouse models of depression J. Med. Chem. 55 2012 8524 8537
112. M.I. Fernández-Bachiller, C. Pérez, L. Monjas, J. Rademann, and M.I. Rodríguez-Franco New tacrine-4-oxo-4 H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties J. Med. Chem. 55 2012 1303 1317
113. S. Impey, D.M. Smith, K. Obrietan, R. Donahue, C. Wade, and D.R. Storm Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning Nat. Neurosci. 1 1998 595 601
114. X. Yu, G. He, and G. Du Neuroprotective effect of baicalein in patients with Parkinson's disease Zhongguo Zhong Yao Za Zhi 37 2012 421 425
115. Y.P. Lin, T.Y. Chen, H.W. Tseng, M.H. Lee, and S.T. Chen Chemical and biological evaluation of nephrocizin in protecting nerve growth factor-differentiated PC12 cells by 6-hydroxydopamine-induced neurotoxicity Phytochemistry 84 2012 102 115
116. R.J. Williams, and J.P.E. Spencer Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease Free Radic. Biol. Med. 52 2012 35 45
117. J.K. Cho, Y.B. Ryu, M.J. Curtis-Long, J.Y. Kim, D. Kim, S. Lee, W.S. Lee, and K.H. Park Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on b-secretase (BACE-1) Bioorg. Med. Chem. Lett. 21 2011 2945 2948
118. I. Uriarte-Pueyo, and M.I. Calvo Flavonoids as acetylcholinesterase inhibitors Curr. Med. Chem. 18 2011 5289 5302
119. R. Sheng, X. Lin, J. Zhang, K.S. Chol, W. Huang, B. Yang, Q. He, and Y. Hu Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors Bioorg. Med. Chem. 17 2009 6692 6698
120. F. Chimenti, R. Fioravanti, A. Bolasco, P. Chimenti, D. Secci, F. Rossi, M. Yáñez, F. Orallo, F. Ortuso, S. Alcaro, R. Cirilli, R. Ferretti, and M.L. Sanna A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors Bioorg. Med. Chem. 18 2010 1273 1279
121. S.S. Kang, J.Y. Lee, Y.K. Choi, S.S. Song, J.S. Kim, S.J. Jeon, Y.N. Han, K.H. Son, and B.H. Han Neuroprotective effects of naturally occurring biflavonoids Bioorg. Med. Chem. Lett. 15 2005 3588 3591
122. J.H. Medina, H. Viola, C. Wolfman, M. Marder, C. Wasowski, D. Calvo, and A.C. Paladini Neuroactive flavonoids: new ligands for the benzodiazepine receptors Phytomedicine 5 1998 235 243 (Pubitemid 128554053)
123. P.W. Baures, S.A. Peterson, and J.W. Kelly Discovering transthyretin amyloid fibril inhibitors by limited screening Bioorg. Med. Chem. 6 1998 1389 1401 (Pubitemid 28398970)
124. Y. Karton, J.L. Jiang, X.D. Ji, N. Melman, M.E. Olah, G.L. Stiles, and K.A. Jacobson Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists J. Med. Chem. 39 1996 2293 2301 (Pubitemid 26191123)
125. I. Setnikar, W. Murmann, M.J. Magistretti, P. De Re, and L. Verlicchi N-Substituted 8-aminomethylchromones, a new class of Central nervous system stimulants J. Med. Pharm. Chem. 3 1961 471 488
126. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790 (Pubitemid 30212409)
127. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820 (Pubitemid 34000785)
128. J. Fuhlendorff, P. Rorsman, H. Kofod, C.L. Brand, B. Rolin, P. MacKay, R. Shymko, and R.D. Carr Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes Diabetes 47 1998 345 351 (Pubitemid 28104194)
129. F. Chiarelli, and D.D. Marzio Peroxisome-proliferator-activated receptor-γ agonists and diabetes: current evidence and future perspectives Vasc. Health Risk Manag. 4 2008 297 304 (Pubitemid 351711958)
130. R.S. Hundal, M. Krssak, S. Dufour, D. Laurent, V. Lebon, V. Chandramouli, S.E. Inzucchi, W.C. Schumann, K.F. Petersen, B.R. Landau, and G.I. Shulman Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2000 2063 2069
131. A.K. Verma, H. Singh, M. Satyanarayana, S.P. Srivastava, P. Tiwari, A.B. Singh, A.K. Dwivedi, S.K. Singh, M. Srivastava, C. Nath, R. Raghubir, A.K. Srivastava, and R. Pratap Flavone-based novel antidiabetic and antidyslipidemic agents J. Med. Chem. 55 2012 4551 4567
132. J.S. Kim, C.S. Kwon, and K.H. Son Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid Biosci. Biotechnol. Biochem. 64 2000 2458 2461
133. T.H. Babu, V.R.S. Rao, A.K. Tiwari, K.S. Babu, P.V. Srinivas, A.Z. Ali, and J.M. Rao Synthesis and biological evaluation of novel 8-aminomethylated oroxylin A analogues as a-glucosidase inhibitors Bioorg. Med. Chem. Lett. 18 2008 1659 1662 (Pubitemid 351318245)
134. H. Gao, and J. Kawabata 2-Aminoresorcinol is a potent a-glucosidase inhibitor Bioorg. Med. Chem. Lett. 18 2008 812 815
135. K.E. Schemmel, S. Rosalyn, R.S. Padiyara, and J.J. D'Souza Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review J. Diabetes Complicat. 24 2010 354 360
136. A.G. Mercader, P.R. Duchowicz, F.M. Fernández, E.A. Castro, D.O. Bennardi, J.C. Autino, and G.P. Romanelli QSAR prediction of inhibition of aldose reductase for flavonoids Bioorg. Med. Chem. 16 2008 7470 7476
137. O. Bozdag-Dündar, E.J. Verspohl, N. Das-Evcimen, R.M. Kaup, K. Bauer, M. SarIkaya, B. Evranos, and R. Ertan Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones Bioorg. Med. Chem. 16 2008 6747 6751
138. X.Q. Zou, S.M. Peng, C.P. Hu, L.F. Tan, Q. Yuan, H.W. Deng, and Y.J. Li Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin Bioorg. Med. Chem. 18 2010 3020 3025
139. M. Kuroda, Y. Mimaki, S. Honda, H. Tanaka, S. Yokota, and T. Mae Phenolics from Glycyrrhiza glabra roots and their PPAR-gamma ligand-binding activity Bioorg. Med. Chem. 18 2010 962 970
140. A. Matin, N. Gavande, M.S. Kim, N.X. Yang, N.K. Salam, J.R. Hanrahan, R.H. Roubin, and D.E. Hibbs 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor α and -γ (PPARalpha and gamma) dual agonists J. Med. Chem. 52 2009 6835 6850
141. A. Matin, M.R. Doddareddy, N. Gavande, S. Nammi, P.W. Groundwater, R.H. Roubin, and D.E. Hibbs The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists Bioorg. Med. Chem. 21 2013 766 778
142. M. Forghieri, C. Laggner, P. Paoli, T. Langer, G. Manao, G. Camici, L. Bondioli, F. Prati, and L. Costantino Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors Bioorg. Med. Chem. 17 2009 2658 2672
143. M. Cushman, H. Zhu, R. Geahlen, and A.J. Kraker Synthesis and biochemical evaluation of a series of aminoflavones as potential inhibitors of protein-tyrosine kinases p56lck, EGFr, and p60v-src J. Med. Chem. 37 1994 3352 3362
144. R.M. Perez, H. Cervantes, M.A. Zavala, J. Sanchez, S. Perez, and C. Perez Isolation and hypoglycemic activity of 5,7,3′-trihydroxy-3,6,4′- trimethoxyflavone from Brickellia veronicaefolia Phytomedicine 7 2000 25 29
145. J.S. Shin, K.S. Kim, M.B. Kim, J.H. Jeong, and B.K. Kim Synthesis and hypoglycemic effect of chrysin derivatives Bioorg. Med. Chem. Lett. 9 1999 869 874
146. H. Matsuda, T. Wang, H. Managi, and M. Yoshikawa Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities Bioorg. Med. Chem. 11 2003 5317 5323 (Pubitemid 37464658)
147. M. Houimel, J.P. Mach, I. Corthésy-Theulaz, B. Corthésy, and I. Fisch New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries Eur. J. Biochem. 262 1999 774 780 (Pubitemid 29291035)
148. W.L. Peterson Helicobacter pylori and peptic ulcer disease N. Engl. J. Med. 324 1991 1043 1048
149. C. La Casa, I. Villegas, C. Alarcón de la Lastra, V. Motilva, and M.J. Martín Calero Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions J. Ethnopharmacol. 71 2000 45 53 (Pubitemid 30440651)
150. K.B. Hahm, Y.J. Song, T.Y. Oh, J.S. Lee, Y.J. Surh, Y.B. Kim, B.M. Yoo, J.H. Kim, S.U. Han, K.T. Nahm, M.W. Kim, D.Y. Kim, and S.W. Cho Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J. Biochem. Mol. Biol. 36 2003 82 94 (Pubitemid 36836260)
151. Y.S. Kim, M. Son, J.I. Ko, H. Cho, M. Yoo, W.B. Kim, I.S. Song, and C.Y. Kim Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease Arch. Pharm. Res. 22 1999 354 360
152. J.S. Lee, H.S. Kim, K.B. Hahm, M.W. Sohn, M. Yoo, J.A. Johnson, and Y.J. Surh Inhibitory effects of 7-carboxymethyloxy-3′,4′,5- trimethoxyflavone (DA-6034) on Helicobacter pylori-induced NF-kappa B activation and iNOS expression in AGS cells Ann. N. Y. Acad. Sci. 1095 2007 527 535 (Pubitemid 47092484)
153. A. Izzo, G.D. Carlo, N. Mascolo, F. Capasso, and G. Autore Antiulcer effect of flavonoids. Role of endogenous PAF Phytother. Res. 8 1994 179 181 (Pubitemid 24171848)
154. S. Sumbul, M.A. Ahmad, and A. Mohd Role of phenolic compounds in peptic ulcer: an overview J. Pharm. Bioallied Sci. 3 2011 361 367
155. J.J. Ares, P.E. Outt, J.L. Randall, J.N. Johnston, P.D. Murray, L.M. O'Brien, P.S. Weisshaar, and B.L. Ems Synthesis and biological evaluation of flavonoids and related compounds as gastroprotective agents Bioorg. Med. Chem. Lett. 6 1996 995 998 (Pubitemid 26147287)
156. J.J. Ares, P.E. Outt, J.L. Randall, P.D. Murray, P.S. Weisshaar, L.M. O'Brien, B.L. Ems, S.V. Kakodkar, G.R. Kelm, and W.C. Kershaw Synthesis and biological evaluation of substituted flavones as gastroprotective agents J. Med. Chem. 38 1996 4937 4943
157. T.H. Babu, K. Manjulatha, G.S. Kumar, A. Hymavathi, A.K. Tiwari, M. Purohit, J.M. Rao, and K.S. Babu Gastroprotective flavonoid constituents from Oroxylum indicum Vent. Bioorg. Med. Chem. Lett. 20 2010 117 120
158. H. Adcock Pharmageddon: is it too late to tackle growing resistance to anti-infectives? Pharm. J. 269 2002 599 600
159. J.B. Harborne, and C.A. Williams Advances in flavonoid research since 1992 Phytochemistry 55 2000 481 504
160. W.F. Zheng, R.X. Tan, L. Yang, and Z.L. Liu Two flavones from Artemisia giraldii and their antimicrobial activity Planta Med. 62 1996 160 162 (Pubitemid 26163222)
161. H.J. Jung, W.S. Sung, S.H. Yeo, H.S. Kim, I.S. Lee, E.R. Woo, and D.G. Lee Antifungal effect of amentoflavone derived from Selaginella tamariscina Arch. Pharm. Res. 29 2006 746 751
162. J. Lee, Y. Choi, E.R. Woo, and D.G. Lee Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina Biochem. Biophys. Res. Commun. 379 2009 676 680
163. K. Isobe, K. Shoji, Y. Nakanishi, M. Yokoe, and N. Wakao Purification and some properties of cholesterol oxidase stable in detergents from gamma-proteobacterium Y-134 J. Biosci. Bioeng. 58 2003 257 263 (Pubitemid 36438882)
164. G. Sagrera, A. Bertucci, A. Vazquez, and G. Seoane Synthesis and antifungal activities of natural and synthetic biflavonoids Bioorg. Med. Chem. 19 2011 3060 3073
165. P. Venkatesan, and T. Maruthavanan Synthesis of substituted flavone derivatives as potent antimicrobial agents Bull. Chem. Soc. Ethiop. 25 2011 419 425
166. S.B.A. Ghani, L. Weaver, Z.H. Zidan, H.M. Ali, C.W. Keevil, and R. Brown Microwave-assisted synthesis and antimicrobial activities of flavonoid derivatives Bioorg. Med. Chem. Lett. 18 2008 518 522
167. B. Sathiamoorthy, P. Gupta, M. Kumar, A.K. Chaturvedi, P.K. Shukla, and R. Maurya New antifungal flavonoid glycoside from Vitex negundo Bioorg. Med. Chem. Lett. 17 2007 239 242 (Pubitemid 46001577)
168. M. Stavri, L.J. Piddock, and S. Gibbons Bacterial efflux pump inhibitors from natural sources J. Antimicrob. Chemother. 59 2007 1247 1260 (Pubitemid 47073343)
169. N.R. Guz, F.R. Stermitz, J.B. Johnson, T.D. Beeson, S. Willen, J. Hsiang, and K. Lewis Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure activity relationships J. Med. Chem. 44 2001 261 268 (Pubitemid 32096671)
170. F.R. Stermitz, P. Lorenz, J.N. Tawara, L.A. Zenewicz, and K. Lewis Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc. Natl. Acad. Sci. U. S. A. 97 2000 1433 1437 (Pubitemid 30118458)
171. F.R. Stermitz, J. Tawara-Matsuda, P. Lorenz, P. Mueller, L. Zenewicz, and K. Lewis 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus J. Nat. Prod. 63 2000 1146 1149
172. K.A. Ohemeng, C.F. Schwender, K.P. Fu, and J.F. Barrett DNA gyrase inhibitory and antibacterial activity of some flavones Bioorg. Med. Chem. Lett. 3 1993 225 230 (Pubitemid 23061416)
173. S.X. Wang, F.J. Zhang, Q.P. Feng, and Y.L. Li Synthesis, characterization, and antibacterial activity of transition metal complexes with 5-hydroxy-7,4′-dimethoxyflavone J. Inorg. Biochem. 46 1992 251 257
174. A. Mori, C. Nishino, N. Enoki, and S. Tawata Antibacterial activity and mode of action of plant flavonoids against Proteus vulgaris and Staphylococcus aureus Phytochemistry 26 1987 2231 2234
175. K. Osawa, H. Yasuda, T. Maruyama, H. Morita, K. Takeya, and H. Itokawa Isoflavanones from the heartwood of Swartzia polyphylla and their antibacterial activity against cariogenic bacteria Chem. Pharm. Bull. Tokyo 40 1992 2970 2974 (Pubitemid 23021862)
176. E.U. Mughal, M. Ayaz, Z. Hussain, A. Hasan, A. Sadiq, M. Riaz, A. Malik, S. Hussain, and M.I. Choudhary Synthesis and antibacterial activity of substituted flavones, 4-thioflavones and 4-iminoflavones Bioorg. Med. Chem. 14 2006 4704 4711 (Pubitemid 43767122)
177. K.S. Babu, K.H. Babu, P.V. Srinivas, K.H. Kishore, U.S.N. Murthy, and J.M. Rao Synthesis and biological evaluation of novel C(7) modified chrysin analogues as antibacterial agents Bioorg. Med. Chem. Lett. 16 2006 221 224 (Pubitemid 41625675)
178. S. Yin, C.Q. Fan, Y. Wang, L. Dong, and J.M. Yue Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study Bioorg. Med. Chem. 12 2004 4387 4392 (Pubitemid 39055642)
179. Y.M. Lin, Y. Zhou, M.T. Flavin, L.M. Zhou, W. Nie, and F.C. Chen Chalcones and flavonoids as anti-tuberculosis agents Bioorg. Med. Chem. 10 2002 2795 2802 (Pubitemid 34626243)
180. Y.M. Lin, T. Flavin, C.S. Cassidy, A. Mar, and F.C. Chen Biflavonoids as novel antituberculosis agents Bioorg. Med. Chem. Lett. 11 2001 2101 2104 (Pubitemid 32763010)
181. H. Goker, D.W. Boykin, and S. Yildiz Synthesis and potent antimicrobial activity of some novel 2-phenyl or methyl-4H-1-benzopyran-4-ones carrying amidinobenzimidazoles Bioorg. Med. Chem. 13 2005 1707 1714 (Pubitemid 40215258)
182. A.L. Liu, H.D. Wang, S.M. Lee, Y.T. Wang, and G.H. Du Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities Bioorg. Med. Chem. 16 2008 7141 7147
183. L. Gao, M. Zu, S. Wu, A.L. Liu, and G.H. Du 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase Bioorg. Med. Chem. Lett. 21 2011 5964 5970
184. Y.B. Ryu, M.J. Curtis-Long, J.W. Lee, H.W. Ryu, J.Y. Kim, W.S. Lee, and K.H. Park Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition Bioorg. Med. Chem. Lett. 19 2009 4912 4915
185. H.J. Jeong, Y.B. Ryu, S.J. Park, J.H. Kim, H.J. Kwon, J.H. Kim, K.H. Park, M.C. Rho, and W.S. Lee Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities Bioorg. Med. Chem. 17 2009 6816 6823
186. K. Miki, T. Nagai, K. Suzuki, R. Tsujimura, K. Koyama, K. Kinoshita, K. Furuhata, H. Yamada, and K. Takahashi Anti-influenza virus activity of biflavonoids Bioorg. Med. Chem. Lett. 17 2007 772 775 (Pubitemid 46108558)
187. P.A. Miller, K.P. Milstrey, and P.W. Trown Specific inhibition of viral ribonucleic acid replication by gliotoxin Science 159 1968 431 432
188. S. Scheller, S. Dworniczak, K. Waldemar-Klimmek, M. Rajca, A. Tomczyk, and J. Shani Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria Z. Naturforsch. C 54 1999 549 553 (Pubitemid 29414018)
189. M. Amoros, C.M. Simões, L. Girre, F. Sauvager, and M. Cormier Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture: comparison with the antiviral activity of propolis J. Nat. Prod. 55 1992 732 1740
190. H.J. Kwon, H.H. Kim, Y.B. Ryu, J.H. Kim, H.J. Jeong, S.W. Lee, J.S. Chang, K.O. Cho, M.C. Rho, S.J. Park, and W.S. Lee In vitro anti-rotavirus activity of polyphenol compounds isolated from the roots of Glycyrrhiza uralensis Bioorg. Med. Chem. 18 2010 7668 7674
191. E. Maeda, M. Akahane, and S. Kiryu Spectrum of Epstein-Barr virus-related diseases: a pictorial review Jpn. J. Radiol. 27 2009 4 19
192. E. Toussirot, and J. Roudier Epstein-Barr virus in autoimmune diseases Best. Pract. Res. Clin. Rheumatol. 22 2008 883 896
193. Y. Iwase, Y. Takemura, M. Ju-ichi, C. Ito, H. Furukawa, S. Kawaii, M. Yano, X.Y. Mou, J. Takayasu, H. Tokuda, and H. Nishino Inhibitory effect of flavonoids from citrus plants on Epstein Barr virus activation and two-stage carcinogenesis of skin tumors Cancer Lett. 154 2000 101 105 (Pubitemid 30229915)
194. Y.M. Lin, D.E. Zembower, M.T. Flavin, R.M. Schure, H.M. Anderson, B.E. Korba, and F. Chen Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro Bioorg. Med. Chem. Lett. 7 1907 2325 2328
195. M. Aregawi, R. Williams, C. Dye, R. Cibulskis, and M. Otten World Malaria 2008 2008 World Health Organization (WHO) Geneva
196. P.L. Rodriguez, and L. Carrasco Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol J. Virol. 66 1992 1971 1976
197. S.K. Sharma, P. Parasuraman, G. Kumar, N. Surolia, and A. Surolia Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR) J. Med. Chem. 50 2007 765 775 (Pubitemid 46332989)
198. M. Dormeyer, Y. Adams, B. Kramer, S. Chakravorty, M.T. Tse, S. Pegoraro, L. Whittaker, M. Lanzer, and A. Craig Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1 Antimicrob. Agents Chemother. 50 2006 724 730 (Pubitemid 43190988)
199. G. Casano, A. Dumetre, C. Pannecouque, S. Hutter, N. Azas, and M. Robin Anti-HIV and antiplasmodial activity of original flavonoid derivatives Bioorg. Med. Chem. 18 2010 6012 6023
200. Z.H. Mbwambo, M.C. Kapingu, M.J. Moshi, F. Machumi, S. Apers, P. Cos, D. Ferreira, J.P. Marais, D. Vanden Berghe, L. Maes, A. Vlietinck, and L. Pieters Antiparasitic activity of some xanthones and biflavonoids from the root bark of Garcinia livingstonei J. Nat. Prod. 69 2006 369 372
201. L. Dhooghe, S. Maregesi, I. Mincheva, D. Ferreira, J.P. Marais, F. Lemière, A. Matheeussen, P. Cos, L. Maes, A. Vlietinck, S. Apers, and L. Pieters Antiplasmodial activity of (I-3,II-3)-biflavonoids and other constituents from Ormocarpum kirkii Phytochemistry 71 2010 785 791
202. G. Auffret, M. Labaied, F. Frappier, P. Rasoanaivo, P. Grellier, and G. Lewin Synthesis and antimalarial evaluation of a series of piperazinyl flavones Bioorg. Med. Chem. Lett. 17 2007 959 963 (Pubitemid 46188532)
203. R. Borges-Argáez, L. Balnbury, A. Flowers, A. Giménez- Turba, G. Ruiz, P.G. Waterman, and L.M. Peña-Rodríguez Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp. Phytomedicine 14 2007 530 533 (Pubitemid 47071883)
204. B. Weniger, C. Vonthron-Senecheau, M. Kaiser, R. Brun, and R. Anton Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids Phytomedicine 13 2006 176 180 (Pubitemid 43120317)
205. P.O. Brown J.M. Con, S.H. Hughes, H.E. Varmus, Retroviruses 1997 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 161 203
206. Y. Kashiwada, A. Aoshima, Y. Ikeshiro, Y.P. Chen, H. Furukawa, M. Itoigawa, T. Fujioka, K. Mihashi, L.M. Cosentino, S.L. Morris-Natschke, and K.H. Lee Bioorg. Med. Chem. 13 2005 443 448
207. V. Veljkovic, J.F. Mouscadet, N. Veljkovic, S. Glisic, and Z. Debyser Simple criterion for selection of flavonoid compounds with anti-HIV activity Bioorg. Med. Chem. Lett. 17 2007 1226 1232 (Pubitemid 46242193)
208. J. Lameira, I.G. Medeiros, M. Reis, A.S. Santos, and C.N. Alves Structure-activity relationship study of flavone compounds with anti-HIV-1 integrase activity: a density functional theory study Bioorg. Med. Chem. 14 2006 7105 7112 (Pubitemid 44403119)
209. D.C. Rowley, M.S. Hansen, D. Rhodes, C.A. Sotriffer, H. Ni, J.A. McCammon, F.D. Bushman, and W. Fenical Thalassiolins A-C: new Marine-Derived inhibitors of HIV cDNA integrase Bioorg. Med. Chem. 10 2002 3619 3625
210. L.A. Friedman, and A.W. Kimball Coronary heart disease mortality and alcohol consumption in Framingham Am. J. Epidemiol. 124 1986 481 489 (Pubitemid 16047364)
211. S.Q. Wang, X.Z. Han, X. Li, D.M. Ren, X.N. Wang, and H.X. Lou Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells Bioorg. Med. Chem. Lett. 20 2010 6411 6415
212. P. Mladenka, L. Zatloukalová, T. Filipský, and R. Hrdina Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity Free Radic. Biol. Med. 49 2010 963 975
213. X.H. Ning, X. Ding, K.F. Childs, S.F. Bolling, and K.P. Gallagher Flavone improves functional recovery after ischemia in isolated reperfused rabbit hearts J. Thorac. Cardiovasc. Surg. 105 1993 541 549 (Pubitemid 23097635)
214. R. Budriesi, A. Bisi, P. Ioan, A. Rampa, S. Gobbi, F. Belluti, L. Piazzi, P. Valenti, and A. Chiarini 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety Bioorg. Med. Chem. 13 2005 3423 3430 (Pubitemid 40552862)
215. J. Lebeau, R. Neviere, and N. Cotelle Beneficial effects of different flavonoids, on functional recovery after ischemia and reperfusion in isolated rat heart Bioorg. Med. Chem. Lett. 11 2001 23 27 (Pubitemid 32006116)
216. E.S. Wu, T.E. Cole, T.A. Davidson, M.A. Dailey, K.G. Doring, M. Fedorchuk, J.T. Loch, T.L. Thomas, J.C. Blosser, A.R. Borrelli, C.R. Kinsolving, R.B. Parker, J.C. Strand, and B.E. Watkins Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties J. Med. Chem. 32 1989 183 192 (Pubitemid 19025309)
217. D.M. Roden Current status of class III antiarrhythmic drug therapy Am. J. Cardiol. 72 1993 44B 49B (Pubitemid 23249063)
218. G.R. Li, H.B. Wang, G.W. Qin, M.W. Jin, Q. Tang, H.Y. Sun, X.L. Du, X.L. Deng, X.H. Zhang, J.B. Chen, L. Chen, X.H. Xu, L.C. Cheng, S.W. Chiu, H.F. Tse, P.M. Vanhoutte, and C.P. Lau Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs Circulation 11 2008 2449 2457 (Pubitemid 351670451)
219. J.R.A. Mitchell, and A.A. Sharp Platelet clumping in vitro Br. J. Haematol. 10 1964 78 93
220. H.H. Ko, H.K. Hsieh, C.T. Liu, H.C. Lin, C.M. Teng, and C.N. Lin Structure-activity relationship studies on chalcone derivatives: potent inhibitor of platelet aggregation J. Pharm. Pharmacol. 54 2004 1333 1337
221. C.M. Teng, S.M. Yu, F.N. Ko, C.C. Chen, W.C. Wang, K.Y. Chen, Y.L. Huang, and T.F. Huang Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles Eur. J. Pharmacol. 26 1991 151 156
222. J. Hirsh, S.S. Anand, J.L. Halperin, and V. Fuster Mechanism of action and pharmacology of unfractionated heparin Arterioscler. Thromb. Vasc. Biol. 21 2001 1094 1096 (Pubitemid 34215133)
223. M. Correia-da-Silva, E. Sousa, B. Duarte, F. Marques, F. Carvalho, L.M. Cunha-Ribeiro, and M.M. Pinto Flavonoids with an oligopolysulfated moiety: a new class of anticoagulant agents J. Med. Chem. 54 2011 95 106
224. T.C. Wang, I.L. Chen, P.J. Lu, C.H. Wong, C.H. Liao, K.C. Tsiao, K.M. Chang, Y.L. Chen, and C.C. Tzeng Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives Bioorg. Med. Chem. 13 2005 6045 6053
225. G.K. Hansson, and A. Hamsten Atherosclerosis, thrombosis, and vascular biology L. Goldman, A.I. Schafer, Cecil Medicine 2011 Saunders Elsevier Philadelphia p70
226. P.J. Barnes, and M. Karin N. Engl. J. Med. 336 1997 1066 1071
227. K. Zibara, E. Chignier, C. Covacho, R. Poston, G. Canard, P. Hardy, and J. McGregor Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice Arterioscler. Thromb. Vasc. Biol. 20 2000 2288 2296
228. M.E. Gerritsen, W.W. Carley, G.E. Ranges, C.P. Shen, S.A. Phan, G.F. Ligon, and C.A. Perry Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression Am. J. Pathol. 147 1995 278 292
229. A. Xagorari, A. Papapetropoulos, A. Mauromatis, M. Economou, T. Fotsis, and C. Roussos Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages J. Pharmacol. Exp. Ther. 296 2001 181 187 (Pubitemid 32015077)
230. C.C. Chen, M.P. Chow, W.C. Huang, Y.C. Lin, and Y.J. Chang Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships Mol. Pharmacol. 66 2004 683 693
231. I. Huk, V. Brovkovych, J. Nanobash Vili, G. Weigel, C. Neumayer, L. Partyka, S. Patton, and T. Malinski Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study Br. J. Surg. 85 1998 1080 1085 (Pubitemid 28360771)
232. S.A. van Acker, M.N. Tromp, G.R. Haenen, W.J. van der Vijgh, and A. Bast Flavonoids as scavengers of nitric oxide radical Biochem. Biophys. Res. Commun. 21 1995 755 759
233. V. García-Mediavilla, I. Crespo, P.S. Collado, A. Esteller, S. Sánchez-Campos, M.J. Tuñón, and J. González-Gallego The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells Eur. J. Pharmacol. 557 2007 221 229 (Pubitemid 46186282)
234. P. Needleman, and P.C. Isakson The discovery and function of COX-2 J. Rheumatol. Suppl. 49 1997 6 8
235. J.R. Dimmock, D.W. Elias, M.A. Beazely, and N.M. Kandepu Bioactivities of chalcones Curr. Med. Chem. 6 1999 1125 1149
236. A. Beretz, M. Joly, J.C. Stoclet, and R. Anton Inhibition of 3′,5′-AMP phosphodiesterase by biflavonoids and xanthones Planta Med. 36 1979 193 195
237. Y.H. Kim, H. Choi, J. Lee, I.C. Hwang, S.K. Moon, S.J. Kim, H.W. Lee, D.S. Im, S.S. Lee, S.K. Ahn, S.W. Kim, C.Y. Han, J.H. Yoon, K.J. Lee, and N.S. Choi Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction Bioorg. Med. Chem. Lett. 18 2008 6279 6282
238. J.C. Le Bail, C. Pouget, C. Fagnere, J.P. Basly, A.J. Chulia, and G. Habrioux Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities Life Sci. 68 2001 751 761 (Pubitemid 32168006)
239. J.E. Ferrell, P.D. Chang Sing, G. Loew, R. King, J.M. Mansour, and T.E. Mansour Structure/Activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices Mol. Pharmacol. 16 1979 556 568 (Pubitemid 10245880)
240. M.R. Nichols, and B.H. Morimoto Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins Mol. Pharmacol. 57 2000 738 745 (Pubitemid 30183714)
241. W.C. Ko, C.M. Shih, Y.H. Lai, J.H. Chem, and H.L. Huang Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships Biochem Pharmacol. 68 2004 2087 2094
242. M.R. Peluso Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver Exp. Biol. Med. 231 2006 1287 1299 (Pubitemid 44330564)
243. R. Rahimi, S. Ghiasi, H. Azimi, S. Fakhari, and M. Abdollahi A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs Cytokine 49 2010 123 129
244. D.A. Parks, and D.N. Granger Xanthine oxidase: biochemistry, distribution and physiology Acta Physiol. Scand. Suppl. 548 1986 87 99 (Pubitemid 16090301)
245. G.B. Elion, S. Callahan, H. Nathan, S. Bieber, R.W. Rundles, and G.H. Hitching Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase Biochem. Pharmacol. 12 1963 85 93
246. J.M. McCord Free radicals and myocardial ischemia: overview and outlook Free Radic. Biol. Med. 4 1988 9 14 (Pubitemid 18037802)
247. U. Takahama, Y. Koga, S. Hirota, and R. Yamauchi Inhibition of xanthine oxidase activity by an oxathiolanone derivative of quercetin Food Chem. 126 2011 1808 1811
248. J. Flemmig, K. Kuchta, J. Arnhold, and H.W. Rauwald Olea europaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase Phytomedicine 18 2011 561 566
249. W.S. Chang, Y.J. Lee, F.J. Lu, and H.C. Chiang Inhibitory effects of flavonoids on xanthine oxidase Anticancer Res. 13 1993 2165 2170
250. N. Nagao, M. Seki, and H. Kobayashi Inhibition of xanthine oxidase by flavonoids Biosci. Biotechnol. Biochem. 63 1999 1787 1790 (Pubitemid 129548408)
251. A.M. Ponce, S.E. Blanco, A.S. Molina, R. García-Domenech, and J. Gálvez Study of the action of flavonoids on xanthine-oxidase by molecular topology J. Chem. Inf. Comput. Sci. 40 2000 1039 1045
252. G. Rastelli, L. Costantino, and A. Albasini A model of the interaction of substrates and inhibitors with xanthine oxidase J. Am. Chem. Soc. 119 1997 3007 3016 (Pubitemid 27204515)
253. J.M. Ntambi, and M. Miyazaki Recent insights into stearoyl-CoA desaturase-1 Curr. Opin. Lipidol. 14 2003 255 261 (Pubitemid 36688204)
254. R.W. Li, A.G. Theriault, K. Au, T.D. Douglas, A. Casaschi, E.M. Kurowska, and R. Mukherjee Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters Life Sci. 79 2006 365 373 (Pubitemid 44172805)
255. L. Guo, W.R. Hu, J.H. Lian, W. Ji, T. Deng, M. Qian, and B.Q. Gong Anti-hyperlipidemic properties of CM108 (a flavone derivative) in vitro and in vivo Eur. J. Pharmacol. 551 2006 80 86 (Pubitemid 44648047)
256. R. Pratap, M. Satyanarayana, C. Nath, R. Raghubir, A. Puri, R. Chander, P. Tiwari, B.K. Tripathi, A.K. Srivastava, Oxy-substituted flavones as antihyperglycemic and antidyslipidemic agents, U.S. Patent US7635779B2, 2009.
257. L.Y. Chung, K.F. Yap, S.H. Goh, M.R. Mustafa, and Z. Imiyabir Muscarinic receptor binding activity of polyoxygenated flavones from Melicope subunifoliolata Phytochemistry 69 2008 1548 1554
258. C.R. Chapple, H. Parkhouse, C. Gardener, and E.J. Milroy Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability Br. J. Urol. 66 1990 491 494 (Pubitemid 20365715)
259. J. Du, S.T. Szabo, N.A. Gray, and H.K. Manji Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders Int. J. Neuropsychopharmacol. 7 2004 243 248 (Pubitemid 39166458)
260. M. Torres-Piedra, M. Figueroa, O. Hernández-Abreu, M. Ibarra-Barajas, G. Navarrete-Vázquez, and S. Estrada-Soto Vasorelaxant effect of flavonoids through calmodulin inhibition: ex vivo, in vitro, and in silico approaches Bioorg. Med. Chem. 19 2011 542 546
261. Z. Chen, Y. Hu, H. Wu, and H. Jiang Synthesis and biological evaluation of flavonoids as vasorelaxant agents Bioorg. Med. Chem. Lett. 14 2004 3949 3952 (Pubitemid 38844402)
262. X. Dong, T. Liu, J. Yan, P. Wu, J. Chen, and Y. Hu Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents Bioorg. Med. Chem. 17 2009 716 726
263. B. Botta, A. Vitalib, P. Menendezc, D. Misitia, and G.D. Monachea Prenylated flavonoids: pharmacology and biotechnology Curr. Med. Chem. 12 2005 713 739 (Pubitemid 40331062)
264. X. Dong, Y. Liu, J. Yan, C. Jiang, J. Chen, T. Liu, and Y. Hu Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents Bioorg. Med. Chem. 16 2008 8151 8160
265. Y.C. Xu, S.W.S. Leung, D.K.Y. Yeung, L.H. Hu, G.H. Chen, C.M. Che, and R.Y.K. Man Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery Phytochemistry 68 2007 1179 1181
266. C.G. Roehrborn, J.G. Nuckolls, J.T. Wei, and W. Steers BPH registry and patient survey steering committee. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics BJU. Int. 100 2007 813 819 (Pubitemid 47360180)
267. L. Black, M.J. Naslund, T.D. Gilbert, E.A. Davis, and D.A. Ollendorf An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia Am. J. Manag. Care 12 2006 S99 S110
268. R. MacDonald, T.J. Wilt, and R.W. Howe Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects BJU. Int. 94 2004 1263 1270 (Pubitemid 40052090)
269. J.P. Hieble, D.C. Kolpak, G.P. McCafferty, R.R. Ruffolo, R. Testa, and A. Leonardi Effects of alpha1-adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity Eur. J. Pharmacol. 373 1999 51 62 (Pubitemid 29306710)
270. R. Testa, L. Guarneri, C. Taddei, E. Poggesi, P. Angelico, A. Sartani, A. Leonardi, O.N. Gofrit, S. Meretyk, and M. Caine Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery J. Pharmacol. Exp. Ther. 277 1996 1237 1246 (Pubitemid 27167133)
271. L. Betti, M. Floridi, G. Giannaccini, F. Manetti, C. Paparelli, G. Strappaghetti, and M. Botta Design, synthesis, and 1 -adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion Bioorg. Med. Chem. 12 2004 1527 1535 (Pubitemid 38296543)
272. H.Y. Han, S. Shan, X. Zhang, N.L. Wang, X.P. Lu, and X.S. Yao Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L. Phytomedicine 14 2007 338 343 (Pubitemid 46654788)
273. I.L. Wong, K.F. Chan, T.H. Chan, and L.M. Chow Flavonoid dimers as novel, potent antileishmanial agents J. Med. Chem. 55 2012 8891 8902
274. D. Tasdemir, M. Kaiser, R. Brun, V. Yardley, T.J. Schmidt, F. Tosun, and P. Rüedi Antitrypanosomal and antileishmanial analogues: in vitro, in vivo, activities of flavonoids and their quantitative structure-activity relationship structure-activity relationship, and studies Antimicrob. Agents Chemother. 50 2006 1352 1364
275. R. Maurya, P. Rawat, K. Sharan, J.A. Siddiqui, G. Swarnkar, G. Mishra, K.R. Arya, N. Chattopadhyay, World Pat. 110003, 2009.
276. P.I. Oteiza, A.G. Erlejman, S.V. Verstraeten, C.L. Keen, and C.G. Fraga Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Dev. Immunol. 12 2005 19 25 (Pubitemid 41647026)
277. F. Ollila, K. Halling, P. Vuorela, H. Vuorela, and J.P. Slotte Characterization of flavonoid-biomembrane interactions Arch. Biochem. Biophys. 399 2002 103 108 (Pubitemid 34848316)
278. I. Kubo, I. Kinst-Hori, S.K. Chaudhuri, Y. Kubo, Y. Sánchez, and T. Ogura Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria Bioorg. Med. Chem. 8 2000 1749 1755 (Pubitemid 30427241)
279. S. Briganti, E. Camera, and M. Picardo Chemical and instrumental approaches to treat hyperpigmentation Pigment. Cell Res. 16 2003 101 110 (Pubitemid 36596955)
280. D.E. Wilcox, A.G. Porras, Y.T. Hwang, K. Lerch, M.E. Winkler, and E.I. Solomon Substrate analog binding to the coupled binuclear copper active site in tyrosinase J. Am. Chem. Soc. 107 1985 4015 4027
281. T. Tatsuhiko Application to cosmetics of oil soluble licorice extract Fragr. J. 17 1989 122 125
282. H. Gao, J. Nishida, S. Saito, and J. Kawabata Inhibitory effects of 5,6,7-trihydroxyflavones on tyrosinase Molecules 12 2007 86 97
283. S. Beutner, B. Bloedorn, S. Frixel, I.H. Blanco, T. Hoffmann, H.D. Martin, B. Mayer, P. Noack, C. Ruck, M. Schmidt, I. Schulke, S. Sell, H. Ernst, S. Haremza, G. Seybold, H. Sies, W. Stahl, and R. Walsh Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: carotenoids, flavonoids, phenols and indigoids. The role of β-carotene in antioxidant functions J. Sci. Food Agric. 81 2001 559 568 (Pubitemid 32386131)
284. E.J. Middleton, and C. Kandaswami Effects of flavonoids on immune and inflammatory cell functions Biochem. Pharmacol. 43 1992 1167 1179
285. J.M. van Noort, A.C. van Sechel, J.J. Bajramovic, M. el Ouagmiri, C.H. Polman, H. Lassmann, and R. Ravid The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis Nature 375 1995 798 801
286. R. Verbeek, A.C. Plomp, E.A. van Tol, and J.M. van Noort The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells Biochem. Pharmacol. 68 2004 621 629 (Pubitemid 38953443)
287. K. Phromnoi, S. Prasad, S.C. Gupta, R. Kannappan, S. Reuter, P. Limtrakul, and B.B. Aggarwal Dihydroxypentamethoxyflavone downregulates constitutive and inducible signal transducers and activators of transcription (STAT)-3 through the induction of tyrosine phosphatase SHP-1 Mol. Pharmacol. 80 2011 889 899
288. W.L. Chang, L.W. Chiu, J.H. Lai, and H.C. Lin Immunosuppressive flavones and lignans from Bupleurum scorzonerifolium Phytochemistry 64 2003 1375 1379
289. K. Sankaranarayanan Estimation of the genetic risks of exposure to ionizing radiation in humans: current status and emerging perspectives J. Radiat. Res. 47 2006 B57 B66
290. M.R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, G. Acerbi, M. Cacchio, A. Di Renzo, S. Stuard, and M. Corsi HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study Angiology 56 2005 165 172 (Pubitemid 40404471)
291. K. Shimoi, S. Masuda, M. Furugori, S. Esaki, and N. Kinae Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice Carcinogenesis 15 1994 2669 2672 (Pubitemid 24343710)
292. P. Uma Devi, A. Ganasoundari, B.S. Rao, and K.K. Srinivasan In vivo radioprotection by ocimum flavonoids: survival of mice Radiat. Res. 151 1999 74 78 (Pubitemid 29069348)
293. R. Arora, R. Chawla, S.C. Puri, R. Sagar, S. Singh, R. Kumar, A.K. Sharma, J. Prasad, S. Singh, G. Kaur, P. Chaudhary, G.N. Qazi, and R.K. Sharma Radioprotective and antioxidant properties of low-altitude. Podophyllum hexandrum (LAPH) J. Environ. Pathol. Toxicol. Oncol. 24 2005 299 314
294. V. Benkovic, A.H. Knezevic, D. Dikic, D. Lisicic, N. Orsolic, I. Basic, I. Kosalec, and N. Kopjar Radioprotective effects of propolis and quercetin in c-irradiated mice evaluated by the alkaline comet assay Phytomedicine 15 2008 851 858
295. U. Blank, C. Ra, L. Miller, K. White, H. Metzger, and J.P. Kinet Complete structure and expression in transfected cells of high affinity IgE receptor Nature 337 1989 187 189 (Pubitemid 19025382)
296. S. Tamura, K. Yoshihira, K. Fujiwara, and N. Murakami New inhibitors for expression of IgE receptor on human mast cell Bioorg. Med. Chem. Lett. 20 2010 2299 2302
297. E.S. Wu, A. Kover, Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase U.S. Patent 4889941, 1989.
298. M.E. Zwaagstra, H. Timmerman, A.C. van de Stolpe, F.J. de Kanter, M. Tamura, Y. Wada, and M.Q. Zhang Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists J. Med. Chem. 41 1998 1428 1438 (Pubitemid 28198972)
299. J.H. Medina, H. Viola, C. Wolfman, M. Marder, C. Wasowski, D. Calvo, and A.C. Paladini Overview-flavonoids: a new family of benzodiazepine receptor ligands Neurochem. Res. 22 1997 419 425 (Pubitemid 27184706)
300. S. Yamamura, K. Ozawa, K. Ohtani, R. Kasai, and K. Yamasak Anti-histaminic flavones and aliphatic glycosides from menthe spicata Phytochemistry 48 1998 131 136 (Pubitemid 28242391)
301. P.J. Whiting, R.M. McKernan, and K.A. Wafford Structure and pharmacology of vertebrate GABA A receptor subtypes R.J. Bradley, R.A. Harris, Inter-National Review of Neurobiology 1995 Academic Press New York 95 138 (Pubitemid 3005336)
302. W. Sieghart Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes Pharmacol. Rev. 47 1995 181 234
303. A/Benzodiazepine Receptor as a Target for Psychoactive Drugs 1996 Springer-Verlag Heidelberg, Germany
304. J. Ai, K. Dekermendjian, O. Sterner, M. Nielsen, and M.R. Witt Compounds isolated from medicinal plants as ligands for benzodiazepine receptors Recent Res. Dev. Phytochem. 1 1997 365 385
305. J.H.M. Medina, H. Viola, C. Wolfman, M. Marder, C. Wasowskj, D. Calvo, and A.C. Paladini Neuroactive flavonoids; new ligands for the benzodiazepine receptors Phytomedicine 5 1998 235 243 (Pubitemid 128554053)
306. K. Dekermendjian, P. Kahnberg, M.R. Witt, O. Sterner, M. Nielsen, and T.
307. P. Kahnberg, E. Lager, C. Rosenberg, J. Schougaard, L. Camet, O. Sterner, E. Stergaard Nielsen, M. Nielsen, and T. Liljefors Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA a receptor J. Med. Chem. 45 2002 4188 4201 (Pubitemid 35025568)
308. J. Nilsson, E.O. Nielsen, T. Liljefors, M. Nielsen, and O. Sterner Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA A receptors Bioorg. Med. Chem. Lett. 18 2008 5713 5716
309. Y.H. Tao, D.Y. Jiang, H.B. Xu, and X.L. Yang Inhibition of GABA shunt enzymes′ activity by 4-hydroxy-benzaldehyde derivatives Bioorg. Med. Chem. Lett. 16 2006 592 595
310. Y.H. Tao, D.Y. Jiang, H.B. Xu, and X.L. Yang Inhibitory effect of Erigeron breviscapus extract and its flavonoid components on GABA shunt enzymes Phytomedicine 15 2008 92 97 (Pubitemid 350297901)
311. A.C. Chao, F.J. de Sauvage, Y.J. Dong, J.A. Wagner, D.V. Goeddel, and P. Gardner Activation of intestinal CFTR Cl channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase EMBO. J. 13 1994 1065 1072 (Pubitemid 24074713)
312. M.R. Picciotto, J.A. Cohn, G. Bertuzzi, P. Greengard, and A.C. Nairn Phosphorylation of the cystic fibrosis transmembrane conductance regulator J. Biol. Chem. 267 1992 12742 12752
313. B. Illek, and H. Fischer Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo Am. J. Physiol. Lung Cell Mol. Physiol. 275 1998 L902 L910
314. B. Illek, M.E. Lizarzaburu, V. Lee, M.H. Nantz, M.J. Kurth, and H. Fischer Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin Am. J. Cell Physiol. 279 2000 C1838 C1846
315. M. Schuier, H. Sies, B. Illek, and H. Fischer Cocoa-Related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia J. Nutr. 135 2005 2320 2325 (Pubitemid 41429584)
316. S. Ayers, D.L. Zink, K. Mohn, J.S. Powell, C.M. Brown, T. Murphy, R. Brand, S. Pretorius, D. Stevenson, D. Thompson, and S.B. Singh Flavones from Struthiola argentea with anthelmintic activity in vitro Phytochemistry 69 2008 541 545